Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
about
Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Inhibition of EGFR or IGF-1R s ...... hibition has no added benefit.
@en
type
label
Inhibition of EGFR or IGF-1R s ...... hibition has no added benefit.
@en
prefLabel
Inhibition of EGFR or IGF-1R s ...... hibition has no added benefit.
@en
P2093
P2860
P356
P1433
P1476
Inhibition of EGFR or IGF-1R s ...... nhibition has no added benefit
@en
P2093
David P Molkentine
David R Valdecanas
Heath Skinner
Kathryn A Mason
Kie-Kian Ang
Raymond E Meyn
Thomas A Buchholz
P2860
P356
10.1002/CAM4.345
P407
P577
2014-10-30T00:00:00Z